ASH: No­var­tis rolls out ear­ly da­ta for a pair of 'sec­ond-gen' CAR-Ts with more pro­duc­tive cells de­liv­ered faster

The cur­rent gen­er­a­tion of cell ther­a­pies has proven a game chang­er in terms of treat­ing ag­gres­sive blood can­cers, but the tech has its lim­i­ta­tions. No­var­tis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER